Radical prostatectomy or radiotherapy for high- and very high-risk prostate cancer: a multidisciplinary prostate cancer clinic experience of patients eligible for either treatment.

Chad A ReichardKaren E HoffmanChad TangStephen B WilliamsPamela K AllenMary F AchimDeborah A KubanBrian F Chapin

Published in: BJU international (2019)

Long-term outcomes appear similar amongst patients with high-risk and VHR prostate cancer deemed eligible for either RP or RT, and treated after consultation in a MDPCC. Outcomes of the MDPCC patients were superior to those of the matched SEER cohort.

Keyphrases

prostate cancer
radical prostatectomy
newly diagnosed
end stage renal disease
ejection fraction
prognostic factors
early stage
type diabetes
squamous cell carcinoma
patient reported outcomes
radiation therapy
insulin resistance
metabolic syndrome
palliative care
patient reported
quality improvement